Merck KGaA Looks To Chinese Medicine For Oncology Candidates
This article was originally published in The Pink Sheet Daily
Executive Summary
Collaboration with China’s Chi-Med is part of an initiative to strengthen Merck’s natural compound expertise, exec tells “The Pink Sheet” DAILY.